Development, manufacturing and marketing of devices for the
detection and separation of rare cells.
Employees: 6
Main Markets:
Patients with Genetic Disorders.
Overview
Cellect Technologies is active in the development, manufacture
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
and marketing of devices for the detection and separation of rare
cells. The company's technology is novel and it has achieved the
stage of successful one-in-million cell separations. The first
applications planned are monitoring of the treatment of cancer
patients and the replacement of amniocentesis by blood test.
14/01/03: Cellect Technologies and Eastman Kodak received BIRD's
support for a mutual project.
